Keyphrases
Scoping Review
100%
Central Giant Cell Granuloma
100%
Denosumab
100%
Adverse Drug Reaction
71%
Remission
14%
Hypercalcemia
14%
Vitamin D
14%
MEDLINE
14%
PubMed
14%
Scopus
14%
Treatment Options
14%
Effective Response
14%
Additional Dose
14%
Locally Aggressive
14%
PRISMA-ScR
14%
Clinical Information
14%
Hypo
14%
Osteolytic Lesions
14%
Vitamin D Supplementation
14%
Drug Imaging
14%
Reaction Test
14%
Imaging Tests
14%
Pharmacology, Toxicology and Pharmaceutical Science
Giant Cell Granuloma
100%
Denosumab
100%
Adverse Drug Reaction
71%
Vitamin D
28%
Recurrent Disease
14%
Subcutaneous Injection
14%
Hypercalcaemia
14%
Bone Atrophy
14%
Remission
14%